Clive S Mason

In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?

M. Unemo, S. Jacobsson, Clive S Mason, 2019, The Journal of antimicrobial chemotherapy.

Machine learning-powered antibiotics phenotypic drug discovery

Hoa Hue Truong, C. Lerner, Fethallah Benmansour, 2019, Scientific Reports.

High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobials

J. Wain, T. Avis, Stephan Beisken, 2020, FEMS microbiology letters.

A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections

L. Coin, Anna Stincone, K. Francis, 2022, Science Translational Medicine.

The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic

K. Garey, T. Avis, S. Reich, 2023, Antimicrobial agents and chemotherapy.

High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae

M. Unemo, S. Jacobsson, Clive S Mason, 2020, The Journal of antimicrobial chemotherapy.

Targeted microbiome-sparing antibiotics.

T. Avis, Clive S Mason, Nawaz Khan, 2021, Drug discovery today.

Machine learning-powered antibiotics phenotypic drug discovery

Fethallah Benmansour, Kenneth Bradley, Andreas Maunz, 2019, Scientific Reports.